Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Chen

Showing results (561-570 of 588) with videos related to

Pageof 59
Sort By:
Science Translational Medicine|September 11, 2024
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AMLBijender Kumar, Anand Singh, Rafet Basar, et al.
Nature|November 7, 2008
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genomeTimothy J Ley, Elaine R Mardis, Li Ding, et al.
Cell|April 7, 2018
Pathogenic Germline Variants in 10,389 Adult CancersKuan-Lin Huang, R Jay Mashl, Yige Wu, et al.
The Journal of Clinical Investigation|June 17, 2021
Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cellsHila Shaim, Mayra Shanley, Rafet Basar, et al.
Cancer Cell|May 9, 2025
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interceptionBo Zhu, Pingjun Chen, Muhammad Aminu, et al.
Blood|September 9, 2020
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cellsMay Daher, Rafet Basar, Elif Gokdemir, et al.
Nature Biotechnology|July 24, 2020
Author Correction: A robust benchmark for detection of germline large deletions and insertionsJustin M Zook, Nancy F Hansen, Nathan D Olson, et al.
Nature Biotechnology|June 17, 2020
A robust benchmark for detection of germline large deletions and insertionsJustin M Zook, Nancy F Hansen, Nathan D Olson, et al.
Nature|June 4, 2025
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cellsHind Rafei, Rafet Basar, Sunil Acharya, et al.
The New England Journal of Medicine|December 27, 2013
Variant GADL1 and response to lithium therapy in bipolar I disorderChien-Hsiun Chen, Chau-Shoun Lee, Ming-Ta Michael Lee, et al.
Pageof 59

Showing results (561-570 of 588) with videos related to

Sort By:
Pageof 59
Science Translational Medicine|September 11, 2024
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AMLBijender Kumar, Anand Singh, Rafet Basar, et al.
Nature|November 7, 2008
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genomeTimothy J Ley, Elaine R Mardis, Li Ding, et al.
Cell|April 7, 2018
Pathogenic Germline Variants in 10,389 Adult CancersKuan-Lin Huang, R Jay Mashl, Yige Wu, et al.
The Journal of Clinical Investigation|June 17, 2021
Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cellsHila Shaim, Mayra Shanley, Rafet Basar, et al.
Cancer Cell|May 9, 2025
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interceptionBo Zhu, Pingjun Chen, Muhammad Aminu, et al.
Blood|September 9, 2020
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cellsMay Daher, Rafet Basar, Elif Gokdemir, et al.
Nature Biotechnology|July 24, 2020
Author Correction: A robust benchmark for detection of germline large deletions and insertionsJustin M Zook, Nancy F Hansen, Nathan D Olson, et al.
Nature Biotechnology|June 17, 2020
A robust benchmark for detection of germline large deletions and insertionsJustin M Zook, Nancy F Hansen, Nathan D Olson, et al.
Nature|June 4, 2025
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cellsHind Rafei, Rafet Basar, Sunil Acharya, et al.
The New England Journal of Medicine|December 27, 2013
Variant GADL1 and response to lithium therapy in bipolar I disorderChien-Hsiun Chen, Chau-Shoun Lee, Ming-Ta Michael Lee, et al.
Pageof 59